Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/09/2010CN101724045A Human epididymis expression sperm binding protein HEL-169 as well as encoding gene and application thereof
06/09/2010CN101724044A Human epididymis expression sperm binding protein HEL-97, encoding gene and application thereof
06/09/2010CN101724043A Human epididymis expression sperm binding protein HEL-89, encoding gene and application thereof
06/09/2010CN101724042A Human epididymis expression sperm binding protein HEL-61, encoding gene and application thereof
06/09/2010CN101724041A Human epididymal expression sperm binding protein HEL-47 as well as encoding gene and application thereof
06/09/2010CN101724040A Human epididymal expression sperm binding protein HEL-44 as well as encoding gene and application thereof
06/09/2010CN101724039A Human epididymal expression sperm binding protein HEL-38 as well as encoding gene and application thereof
06/09/2010CN101724038A Human epididymis expression sperm binding protein HEL-5, encoding gene and application thereof
06/09/2010CN101724037A Human epididymis expression sperm binding protein HEL-6, encoding gene and application thereof
06/09/2010CN101724036A Human epididymal expression sperm binding protein HEL-45 as well as encoding gene and application thereof
06/09/2010CN101724035A Human epididymal expression sperm binding protein HEL-43 as well as encoding gene and application thereof
06/09/2010CN101724034A Human epididymal expression sperm binding protein HEL-40 as well as encoding gene and application thereof
06/09/2010CN101724033A Human epididymal expression sperm binding protein HEL-28 as well as encoding gene and application thereof
06/09/2010CN101724032A Human epididymis expression sperm binding protein HEL-9, encoding gene and application thereof
06/09/2010CN101724029A Anti-tumor protein and preparation method and application thereof
06/09/2010CN101724026A Melanocortin analogue as well as preparation method and application thereof
06/09/2010CN101724025A Anti-tumor toad polypeptide and preparation method and application thereof
06/09/2010CN101724022A inhibitors of serine proteases, particularly hcv ns3-ns4a protease
06/09/2010CN101724021A Polypeptide conjugates of taxol or docetaxel
06/09/2010CN101724019A Thymopeptide-5 active esters, medicinal composition containing same and application thereof
06/09/2010CN101724017A 4-nitro-L-phenylalanine dipeptide derivatives as well as preparation method and applications thereof
06/09/2010CN101724016A Peptide compound and preparation method and application thereof
06/09/2010CN101724015A Alpha-glucosidase inhibitor and preparation method thereof
06/09/2010CN101721738A High-voltage electrostatic diabetic foot medication film
06/09/2010CN101721712A Double-chain polyethylene glycol-insulin compound and preparation method thereof
06/09/2010CN101721705A Sleep-easy preparation- efficient endogenous physiological regulating control agent
06/09/2010CN101721691A Preparation for treating and restoring infective wound surface and preparation method thereof
06/09/2010CN101721690A Application of PTD-SOD fusion protein in anti-intoxication alcohol neutralizing product
06/09/2010CN101721689A Fibronectin preparation
06/09/2010CN101721688A Cerebral protection perfusate based on interventional neuroradiology microcatheter technology and preparation method thereof
06/09/2010CN101721687A Insulin-hydroxyapatite nano compound, preparation method and application thereof
06/09/2010CN101721686A Interferon-thymosin broad-spectrum antiviral pharmaceutical preparation for pigs and preparation method thereof
06/09/2010CN101721685A Animal interferon liquid spray and preparation method thereof
06/09/2010CN101721684A Immunowakeup microsystem as well as preparation method and application thereof
06/09/2010CN101721683A Application of human Keratiocyte growth factor 1 in preparation of medicament for treating anal fissure
06/09/2010CN101721682A Application of recombinant human fibroblast growth factor 7 mutant in preparing medicament for treating cervical erosion
06/09/2010CN101721681A Application of human Keratiocyte growth factor 1 in preparation of medicament for treating foot ulcers and leg ulcers of diabetes
06/09/2010CN101721680A Application of variable lymphocyte receptor (VLR) of agnatha in pharmacy
06/09/2010CN101721679A Pharmaceutical compositions for prevention or treatment of lewis y antigen related diseases and kits for detecting lewis y antigen
06/09/2010CN101721678A New antipsoriatic medicine
06/09/2010CN101721677A Thymopentin oral microsphere preparation and preparation method thereof
06/09/2010CN101721676A Gene regulatory peptides
06/09/2010CN101721376A Calcitonin sustained release microsphere composition and preparation method thereof
06/09/2010CN101721375A Insulin slow release micron sphere composition and preparation method thereof
06/09/2010CN101721370A Goserelin release microsphere preparation, preparation method and detecting method thereof
06/09/2010CN101721358A Eye drops containing recombinant human keratinocyte growth factor-2 and application thereof in treating xeroma
06/09/2010CN101721349A Injectable in-situ crosslinking aquogel and preparation method and application thereof
06/09/2010CN101720928A Combination for preventing and curing degenerative disease of bone and joint
06/09/2010CN101230339B Bombina maxima non-crystalline beta gamma-crystallin and trefoil factor protein compound ,gene as well as preparation and use thereof
06/09/2010CN101190943B Jiangzhe snake venom double-chain peptide, preparation method and application thereof
06/09/2010CN101186646B Application of king cobra toxin protease inhibitor and its derivatives
06/09/2010CN101130067B Preparation for replenishing collagen and method of preparing the same
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732580 include a recombinant polypeptide that contains from its N-terminus to C-terminus a C-terminal fragment of MAP protein Map3527, a Map1519 protein amino acid sequence, followed by an N-terminal portion of Map3527; Johne's disease
06/08/2010US7732576 for identification on human chromosome 10 of a tumor suppressor gene;
06/08/2010US7732574 Wound care products containing keratin
06/08/2010US7732573 Method for producing porous body comprising apatite/collagen composite fibers
06/08/2010US7732572 Modified growth hormone protein for use in prevention and treatment of cachexia associated with secondary effect of viral or metabolic diseases
06/08/2010US7732571 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue
06/08/2010US7732568 Methods for preventing and treating Alzheimer's disease
06/08/2010US7732567 Methods and compositions for modulating and detecting wisp activity
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732563 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/08/2010US7732427 Multifunctional and biologically active matrices from multicomponent polymeric solutions
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732417 Methods and compositions for RNA interference using recombinant Dicer and Argonaut
06/08/2010US7732415 Topical treatment or prevention of ocular infections
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/08/2010US7732412 Methods of treatment using novel LHRH antagonists having improved solubility properties
06/08/2010US7732411 Methods of therapy with thrombin derived peptides
06/08/2010US7732410 applying an antiproliferative agent capable of removing sialic acid residues, such as trans-sialidase, neuraminidase with plant extracts comprising nucleic acid-containing particles from garlic, ginkgo, tomato, orchid, guava, ginseng, ginger, and tobacco; anticholesterol agent
06/08/2010US7732409 EspFU nucleic acids and proteins and uses thereof
06/08/2010US7732408 increases dairy cattle breeding efficiency with a reduction in the number of months in the breeding cycle without the need for detecting standing estrus of a dairy cow prior to insemination; administering progesterone; without use of heat detection prior to insemination
06/08/2010US7732407 Method for treatment of demyelinating central nervous system disease
06/08/2010US7732406 intravenously administering an aqueous solution containing mannitol and an effective amount of urodilatinto to the patient continuously
06/08/2010US7732405 comprising a stabilizing benzamidine compound for control the chemical and/or physical degradation products such as enzymatic degradation or autocatalysis products; in air-tight container, antioxidant-free
06/08/2010US7732404 composition for administering to eye, comprising tricaprin, ethyl lactate and surfactants sorbitan oleate, and cyclosporin; high bioavailability
06/08/2010US7732403 Treatment of T-cell mediated diseases
06/08/2010US7732401 Inhibitor of TGF-β activation reaction
06/08/2010US7732400 Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
06/08/2010US7732399 complexes composed of a protein or peptide and a gallic acid ester that allow for sustained delivery of the protein or peptide in vivo upon administration of the complex; gallic acid ester is epigallocatechin gallate; for drug delivery
06/08/2010US7732398 Medicinal uses of mu-opioid receptor agonists
06/08/2010US7732397 Use of cardiotrophin in liver diseases
06/08/2010US7732209 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
06/08/2010US7732207 Method for expression of small antiviral RNA molecules within a cell
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
06/08/2010US7732197 Recombinant nucleic acid of a nucleotide sequence encoding an autocatalytically cleaving and trans-acting ribozymes linked to a tissue-specific or pathogen-specific promoter; anticancer or antiproliferative agents
06/08/2010US7732193 Expressing preferential nucleotide sequences in cells; obtain cell, transfect, recover packaged retrovirus, infect target cell, monitor gene expression in cell
06/08/2010US7732188 Protozoan strains of reduced virulence and use thereof
06/08/2010US7732182 Antisense agents for use intreatment and prevention of nervous system, bone skin, cell proliferative, inflammatory, pain and viral disorders
06/08/2010US7732159 Using plasminogin activator concentration as indicator of tumor progress and antitumor drug efficacy
06/08/2010US7732130 Immunoprotective influenza antigen and its use in vaccination
06/08/2010US7731979 Protective antigen having fluorinated histidine residues
06/08/2010US7731977 treating pruritis associated with psychosis by local administration; skin itching, hallucinations obsessive compulsive disorders treated by low dose, intramuscular administration of botulinum toxin
06/08/2010US7731973 Administering estriol to treat multiple sclerosis, autoimmune diseases, psoriasis, Sjogren's syndrome, encephalomyelitis; inflammatory bowel, Crohn's, Hashimoto's, or Addison's disease; diabetes, myasthenia gravis, lupus, rheumatoid arthritis, polymyositis; immunotherapy; magnetic resonance imaging
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010US7731959 Antagonists of neuropilin receptor function and use thereof
1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 3163